This study offers new insights into the immunological landscape of NPC, adding evidence of the prognostic value of TILs and the potential mechanism of PDL1/PD1 axis blockade in the era of immune-modulatory therapy. Here, PDCD1 is linked to nasopharyngeal carcinoma.